Clinical Trial: Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase IIa, Double Blind, Randomized, Sequential Group Study to Evaluate the Safety and Efficacy of Topical NVC-422 Dermal Gel in Impetigo

Brief Summary: This is a randomized, double-blind study comparing 0.1% NVC-422, 0.5% NVC-422 and 1.5% NVC-422 topical gel in children with impetigo.